Help us beat cancer!

Invest Now

Videos

CEO Podcast

ryan

Watch our CEO, Ryan Davies, chat with leaders and experts in the biotech industry about trends, insights as well as progress with CancerVAX

CancerVAX CEO Discusses Expanded Pipeline at UCLA

August 14, 2023 - Steven Jonas - UCLA

June 28 , 2023 - Lara Sullivan - Pyxis Oncology

June 16, 2023 - Michael Smith - KalVista Pharmaceuticals

May 24, 2023 - Raymond Vennare - Predictive Oncology Inc.

May 17, 2023 - Dr. Dinesh Patel - Xenocor, Inc.

Apr 20, 2023 - Stephen Diamond - LEXEO Therapeutics

Apr 12, 2023 - Dr. Satiro De Oliveira - UCLA

Mar 23, 2023 - Ryan looper - Curza

Mar 21, 2023 - Jonathan Lakey - XOStem, Inc

Mar 19, 2023 - Dr. David Bearss - Halia Therapeutics

Mar 15, 2023 - Todd Kinard - Curza

Mar 15, 2023 - Partnered with Jonsson Comprehensive Cancer Center

Mar 15, 2023 - Seeking Immunotherapy Solutions that Prevent Cancer

Unlike Any Other Industry - CancerVAX CEO Ryan Davies talks Biotech

Mar 15, 2023 - Biomedical Research without Traditional Overhead Costs at CancerVA

This Reg A+ offering is made available through StartEngine Primary, LLC, member FINRA/SIPC. This investment is speculative, illiquid, and involves a high degree of risk, including the possible loss of your entire investment. You should read the Selected Risks, the Offering Circular, and Sec Edgar Page before investing.